A Comparison of the Costs and Benefits of Recombinant Human Erythropoietin (Epoetin) in the Treatment of Chronic Renal Failure in 5 European Countries

This publication has 10 references indexed in Scilit:

• The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group.
  1990
• Recombinant Interferon Alfa Therapy for Chronic Hepatitis C
  New England Journal of Medicine, 1989
• Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
  New England Journal of Medicine, 1989
• Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
  New England Journal of Medicine, 1989
• A Cluster of HIV Infection among Heterosexual People without Apparent Risk Factors
  New England Journal of Medicine, 1989
• Seizures related to blood transfusion and erythropoietin treatment in patients undergoing dialysis.
  BMJ, 1989
• Clinical Implications of Positive Tests for Antibodies to Human Immunodeficiency Virus Type 1 in Asymptomatic Blood Donors
  New England Journal of Medicine, 1989
• Haemodialysis Efficiency After Long-Term Treatment with Recombinant Human Erythropoietin
  Nephrology Dialysis Transplantation, 1989
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986
• A Scale of Valuations of States of Illness: is there a Social Consensus?
  International Journal of Epidemiology, 1978